Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Haferlach

Showing results (11-20 of 596) with videos related to

Pageof 60
Sort By:
Blood|November 12, 2020
Human and artificial intelligence to illuminate MDSTorsten Haferlach
Leukemia Research|September 19, 2012
Molecular genetics in myelodysplastic syndromesTorsten Haferlach
International Journal of Laboratory Hematology|February 3, 2023
Challenging gold standard hematology diagnostics through the introduction of whole genome sequencing and artificial intelligenceTorsten Haferlach, Wencke Walter
British Journal of Haematology|December 7, 2019
The power and potential of integrated diagnostics in acute myeloid leukaemiaTorsten Haferlach, Ines Schmidts
Current Oncology Reports|August 7, 2002
Cytogenetics in acute myeloid leukemiaClaudia Schoch, Torsten Haferlach
Blood|October 12, 2013
Another piece of the AML puzzleClaudia Haferlach, Torsten Haferlach
Blood|March 9, 2019
More than a fusion gene: the <i>RUNX1</i>-<i>RUNX1T1</i> AMLTorsten Haferlach, Manja Meggendorfer
The New England Journal of Medicine|April 16, 2004
Gene-expression profiling in acute myeloid leukemiaDavid Grimwade, Torsten Haferlach
Haematologica|December 4, 2012
The benefit of population-based studies for older patients with acute myeloid leukemiaUlrike Bacher, Torsten Haferlach
Medizinische Klinik (Munich, Germany : 1983)|January 18, 2005
[Quantification of minimal residual disease by multiparameter flow cytometry in acute myeloid leukemia. From diagnosis to prognosis]Wolfgang Kern, Torsten Haferlach
Pageof 60

Showing results (11-20 of 596) with videos related to

Sort By:
Pageof 60
Blood|November 12, 2020
Human and artificial intelligence to illuminate MDSTorsten Haferlach
Leukemia Research|September 19, 2012
Molecular genetics in myelodysplastic syndromesTorsten Haferlach
International Journal of Laboratory Hematology|February 3, 2023
Challenging gold standard hematology diagnostics through the introduction of whole genome sequencing and artificial intelligenceTorsten Haferlach, Wencke Walter
British Journal of Haematology|December 7, 2019
The power and potential of integrated diagnostics in acute myeloid leukaemiaTorsten Haferlach, Ines Schmidts
Current Oncology Reports|August 7, 2002
Cytogenetics in acute myeloid leukemiaClaudia Schoch, Torsten Haferlach
Blood|October 12, 2013
Another piece of the AML puzzleClaudia Haferlach, Torsten Haferlach
Blood|March 9, 2019
More than a fusion gene: the <i>RUNX1</i>-<i>RUNX1T1</i> AMLTorsten Haferlach, Manja Meggendorfer
The New England Journal of Medicine|April 16, 2004
Gene-expression profiling in acute myeloid leukemiaDavid Grimwade, Torsten Haferlach
Haematologica|December 4, 2012
The benefit of population-based studies for older patients with acute myeloid leukemiaUlrike Bacher, Torsten Haferlach
Medizinische Klinik (Munich, Germany : 1983)|January 18, 2005
[Quantification of minimal residual disease by multiparameter flow cytometry in acute myeloid leukemia. From diagnosis to prognosis]Wolfgang Kern, Torsten Haferlach
Pageof 60